Comparison of Quantitative Hippocampal Volumes and Structured Scoring Scales in Predicting Alzheimer Disease Diagnosis

References

1. 1.↵
   World Health Organization. International statistical classification of diseases and related health problems. 2016 (10th ed.). Available at: https://icd.who.int/browse10/2016/en. Accessed October 3, 2023
2. 2.↵
   Alzheimer’s Disease International. Number of People with Dementia Around the World. 2017. https://www.alzint.org/u/numbers-people-with-dementia-2017.pdf. Accessed April 25, 2023
3. 3.↵
   1. Petersen RC

   . Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183–94 doi:10.1111/j.1365-2796.2004.01388.x pmid:15324362

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Vernooij MW,
   2. Pizzini FB,
   3. Schmidt R, et al

   . Dementia imaging in clinical practice: a European-wide survey of 193 centres and conclusions by the ESNR working group. Neuroradiology 2019;61:633–42 doi:10.1007/s00234-019-02188-y pmid:30852630

   CrossRefPubMed
5. 5.↵
   1. Pemberton HG,
   2. Zaki LA,
   3. Goodkin O, et al

   . Technical and clinical validation of commercial automated volumetric MRI tools for dementia diagnosis: a systematic review. Neuroradiology 2021;63:1773–89 doi:10.1007/s00234-021-02746-3 pmid:34476511

   CrossRefPubMed
6. 6.↵
   1. Scheltens P,
   2. van de Pol L

   . Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 2012;83:1038–40 doi:10.1136/jnnp-2012-302562 pmid:22566596

   FREE Full Text
7. 7.↵
   1. Enkirch SJ,
   2. Traschutz A,
   3. Muller A, et al

   . The ERICA score: an MR imaging-based visual scoring system for the assessment of entorhinal cortex atrophy in Alzheimer disease. Radiology 2018;288:226–333 doi:10.1148/radiol.2018171888 pmid:29514015

   CrossRefPubMed
8. 8.↵
   1. McKhann GM,
   2. Knopman DS,
   3. Chertkow H, et al

   . The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:263–69 doi:10.1016/j.jalz.2011.03.005 pmid:21514250

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Molinder A,
   2. Ziegelitz D,
   3. Maier SE, et al

   . Validity and reliability of the medial temporal lobe atrophy scale in a memory clinic population. BMC Neurol 2021;21:289 doi:10.1186/s12883-021-02325-2 pmid:34301202

   CrossRefPubMed
10. 10.↵
    1. Dubois B,
    2. Feldman HH,
    3. Jacova C, et al

    . Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol 2010;9:1118–27 doi:10.1016/S1474-4422(10)70223-4 pmid:20934914

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Laakso MP,
    2. Soininen H,
    3. Partanen K, et al

    . MRI of the hippocampus in Alzheimer’s disease: sensitivity, specificity, and analysis of the incorrectly classified subjects. Neurobiol Aging 1998;19:23–31 doi:10.1016/s0197-4580(98)00006-2 pmid:9562499

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Min J,
    2. Moon WJ,
    3. Jeon JY, et al

    . Diagnostic efficacy of structural MRI in patients with mild-to-moderate Alzheimer disease: automated volumetric assessment versus visual assessment. AJR Am J Roentgenol 2017;208:617–23 doi:10.2214/AJR.16.16894 pmid:28075620

    CrossRefPubMed
13. 13.↵
    1. Falgas N,
    2. Sanchez-Valle R,
    3. Bargallo N, et al

    . Hippocampal atrophy has limited usefulness as a diagnostic biomarker on the early onset Alzheimer’s disease patients: a comparison between visual and quantitative assessment. Neuroimage Clin 2019;23:101927 doi:10.1016/j.nicl.2019.101927 pmid:31491836

    CrossRefPubMed
14. 14.↵
    1. Wei M,
    2. Shi J,
    3. Ni J, et al

    . A new age-related cutoff of medial temporal atrophy scale on MRI improving the diagnostic accuracy of neurodegeneration due to Alzheimer’s disease in a Chinese population. BMC Geriatr 2019;19:59 doi:10.1186/s12877-019-1072-8 pmid:30819102

    CrossRefPubMed
15. 15.↵
    1. Du AT,
    2. Schuff N,
    3. Kramer JH, et al

    . Higher atrophy rate of entorhinal cortex than hippocampus in AD. Neurology 2004;62:422–27 doi:10.1212/01.wnl.0000106462.72282.90 pmid:14872024

    CrossRefPubMed
16. 16.↵
    1. Bottero V,
    2. Powers D,
    3. Yalamanchi A, et al

    . Key disease mechanisms linked to Alzheimer's disease in the entorhinal cortex. Int J Mol Sci 2021;22:3915 doi:10.3390/ijms22083915 pmid:33920138

    CrossRefPubMed
17. 17.↵
    1. Fagone P,
    2. Mangano K,
    3. Martino G, et al

    . Characterization of altered molecular pathways in the entorhinal cortex of Alzheimer’s disease patients and in silico prediction of potential repurposable drugs. Genes (Basel) 2022;13:703 doi:10.3390/genes13040703 pmid:35456509

    CrossRefPubMed
18. 18.↵
    1. Wahlund LO,
    2. Julin P,
    3. Lindqvist J, et al

    . Visual assessment of medial temporal lobe atrophy in demented and healthy control subjects: correlation with volumetry. Psychiatry Res 1999;90:193–99 doi:10.1016/s0925-4927(99)00016-5 pmid:10466738

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Bresciani LC,
    2. Rossi R,
    3. Testa C, et al

    . Visual assessment of medial temporal atrophy on MR films in Alzheimer’s disease: comparison with volumetry. Aging Clin Exp Res 2005;17:8–13 doi:10.1007/BF03337714 pmid:15847116

    CrossRefPubMed
20. 20.↵
    1. Claus JJ,
    2. Staekenborg SS,
    3. Holl DC, et al

    . Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer’s disease: validation in a large memory clinic population. Eur Radiol 2017;27:3147–55 doi:10.1007/s00330-016-4726-3 pmid:28083697

    CrossRefPubMed
21. 21.↵
    1. Traschütz A,
    2. Enkirch SJ,
    3. Polomac N, et al

    . The entorhinal cortex atrophy score is diagnostic and prognostic in mild cognitive impairment. J Alzheimers Dis 2020;75:99–108 doi:10.3233/JAD-181150 pmid:32250289

    CrossRefPubMed
22. 22.↵
    1. Roberge X,
    2. Brisson M,
    3. Laforce RJ

    . Specificity of entorhinal atrophy MRI scale in predicting Alzheimer’s disease conversion. Can J Neurol Sci 2023;50:112–14 doi:10.1017/cjn.2021.253 pmid:34742361

    CrossRefPubMed